AQR Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $641K | Buy |
135,724
+84,164
| +163% | +$397K | ﹤0.01% | 2469 |
|
|
2025
Q1 | $237K | Buy |
51,560
+1,581
| +3% | +$7.26K | ﹤0.01% | 2800 |
|
|
2024
Q4 | $239K | Sell |
49,979
-15,944
| -24% | -$76.4K | ﹤0.01% | 2601 |
|
|
2024
Q3 | $309K | Sell |
65,923
-9,966
| -13% | -$46.7K | ﹤0.01% | 2382 |
|
|
2024
Q2 | $429K | Buy |
75,889
+48,945
| +182% | +$277K | ﹤0.01% | 2119 |
|
|
2024
Q1 | $111K | Buy |
26,944
+10,699
| +66% | +$44K | ﹤0.01% | 2329 |
|
|
2023
Q4 | $68.6K | Buy |
+16,245
| New | +$68.6K | ﹤0.01% | 2295 |
|
|
2019
Q3 | – | Sell |
-17,911
| Closed | -$252K | – | 2166 |
|
|
2019
Q2 | $252K | Hold |
17,911
| – | – | ﹤0.01% | 1921 |
|
|
2019
Q1 | $330K | Buy |
17,911
+3,916
| +28% | +$72.2K | ﹤0.01% | 1934 |
|
|
2018
Q4 | $366K | Buy |
+13,995
| New | +$366K | ﹤0.01% | 1893 |
|
|
2018
Q1 | – | Sell |
-11,896
| Closed | -$181K | – | 2281 |
|
|
2017
Q4 | $181K | Hold |
11,896
| – | – | ﹤0.01% | 2166 |
|
|
2017
Q3 | $213K | Sell |
11,896
-13,477
| -53% | -$241K | ﹤0.01% | 2157 |
|
|
2017
Q2 | $414K | Hold |
25,373
| – | – | ﹤0.01% | 1957 |
|
|
2017
Q1 | $355K | Buy |
25,373
+11,400
| +82% | +$160K | ﹤0.01% | 1977 |
|
|
2016
Q4 | $223K | Buy |
+13,973
| New | +$223K | ﹤0.01% | 2131 |
|
|
2015
Q1 | – | Sell |
-12,413
| Closed | -$178K | – | 2322 |
|
|
2014
Q4 | $178K | Sell |
12,413
-31,900
| -72% | -$457K | ﹤0.01% | 2385 |
|
|
2014
Q3 | $460K | Hold |
44,313
| – | – | ﹤0.01% | 1973 |
|
|
2014
Q2 | $717K | Sell |
44,313
-30,200
| -41% | -$489K | ﹤0.01% | 1811 |
|
|
2014
Q1 | $1.21M | Hold |
74,513
| – | – | ﹤0.01% | 1602 |
|
|
2013
Q4 | $925K | Buy |
74,513
+39,413
| +112% | +$489K | ﹤0.01% | 1772 |
|
|
2013
Q3 | $385K | Buy |
35,100
+20,200
| +136% | +$222K | ﹤0.01% | 2106 |
|
|
2013
Q2 | $120K | Buy |
+14,900
| New | +$120K | ﹤0.01% | 2269 |
|